Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:23031749

Cancer classification: Mutual information, target network and strategies of therapy.

Wen-Chin Hsu · Chan-Cheng Liu · Fu Chang · Su-Shing Chen

Journal of clinical bioinformatics · 2012 doi:10.1186/2043-9113-2-16

Paper

complete

Experiment

complete

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:23031749
kind
science-record
content_hash
sha256:67b0d56230521bcc070349e1daa0fcd1d2aa745b0f7fa5d635276a22cdb08850
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:02Z
updated_at
2026-11-01T21:58:09Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Cancer classification: Mutual information, target network and strategies of therapy.
doi
10.1186/2043-9113-2-16
pmid
23031749
authors array · 4 items
[0]
Wen-Chin Hsu
[1]
Chan-Cheng Liu
[2]
Fu Chang
[3]
Su-Shing Chen
journal
Journal of clinical bioinformatics
year
2012
abstract
BACKGROUND: Cancer therapy is a challenging research area because side effects often occur in chemo and radiation therapy. We intend to study a multi-targets and multi-components design that will provide synergistic results to improve efficiency of cancer therapy. METHODS: We have developed a general methodology, AMFES (Adaptive Multiple FEature Selection), for ranking and selecting important cancer biomarkers based on SVM (Support Vector Machine) classification. In particular, we exemplify this method by three datasets: a prostate cancer (three stages), a breast cancer (four subtypes), and another prostate cancer (normal vs. cancerous). Moreover, we have computed the target networks of these biomarkers as the signatures of the cancers with additional information (mutual information between biomarkers of the network). Then, we proposed a robust framework for synergistic therapy design approach which includes varies existing mechanisms. RESULTS: These methodologies were applied to three GEO datasets: GSE18655 (three prostate stages), GSE19536 (4 subtypes breast cancers) and GSE21036 (prostate cancer cells and normal cells) shown in. We selected 96 biomarkers for first prostate cancer dataset (three prostate stages), 72 for breast cancer (luminal A vs. luminal B), 68 for breast cancer (basal-like vs. normal-like), and 22 for another prostate cancer (cancerous vs. normal. In addition, we obtained statistically significant results of mutual information, which demonstrate that the dependencies among these biomarkers can be positive or negative. CONCLUSIONS: We proposed an efficient feature ranking and selection scheme, AMFES, to select an important subset from a large number of features for any cancer dataset. Thus, we obtained the signatures of these cancers by building their target networks. Finally, we proposed a robust framework of synergistic therapy for cancer patients. Our framework is not only supported by real GEO datasets but also aim to a multi-targets/multi-components drug design tool, which improves the traditional single target/single component analysis methods. This framework builds a computational foundation which can provide a clear classification of cancers and lead to an efficient cancer therapy.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
We then apply the MI calculation described in the Mutual Information section on 96 biomarkers for GSE18655 and represent the pairwise MI values of grade 1, grade 2 and grade 3 samples in three 96*96 matrixes which can be found in Additional file 5 GSE18655 Grade1 MI.xlsx, Additional file 6 GSE18655 Grade2 MI.xlsx and Additional file 7 GSE18655 Grade3 MI.xlsx.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:23031749
locator
sections[17] "Results of AMFES" paragraph 4
quote
We then apply the MI calculation described in the Mutual Information section on 96 biomarkers for GSE18655 and represent the pairwise MI values of grade 1, grade 2 and grade 3 samples in three 96*96 matrixes which can be found in Additional file 5 GSE18655 Grade1 MI.xlsx, Additional file 6 GSE18655 Grade2 MI.xlsx and Additional file 7 GSE18655 Grade3 MI.xlsx.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.
kind
methodological
target
null
evidence array · 2 items
[0] object · 3 fields
asset
source:pmid:23031749
locator
sections[14] "The prostate cancer dataset with RNA biomarkers" paragraph 3
quote
The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21].
[1] object · 3 fields
asset
source:pmid:23031749
locator
sections[14] "The prostate cancer dataset with RNA biomarkers" paragraph 3
quote
Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
The paper used AMFES-based SVM classification with mutual-information analysis on three GEO datasets—GSE18655, GSE19536, and GSE21036—and selected 96 biomarkers for three-stage prostate cancer, 72 for luminal-versus-basal/normal breast cancer, 68 for basal-like-versus-normal-like breast cancer, and 22 for prostate cancerous-versus-normal classification.
kind
qualitative
target
null
evidence array · 4 items
[0] object · 3 fields
asset
source:pmid:23031749
locator
sections[0] "Abstract" paragraph 2
quote
We have developed a general methodology, AMFES (Adaptive Multiple FEature Selection), for ranking and selecting important cancer biomarkers based on SVM (Support Vector Machine) classification.
[1] object · 3 fields
asset
source:pmid:23031749
locator
sections[0] "Abstract" paragraph 3
quote
These methodologies were applied to three GEO datasets: GSE18655 (three prostate stages), GSE19536 (4 subtypes breast cancers) and GSE21036 (prostate cancer cells and normal cells) shown in.
[2] object · 3 fields
asset
source:pmid:23031749
locator
sections[0] "Abstract" paragraph 3
quote
We selected 96 biomarkers for first prostate cancer dataset (three prostate stages), 72 for breast cancer (luminal A vs. luminal B), 68 for breast cancer (basal-like vs. normal-like), and 22 for another prostate cancer (cancerous vs. normal.
[3] object · 3 fields
asset
source:pmid:23031749
locator
sections[18] "Results of calculating mutual information" paragraph 2
quote
The statistic results of calculating mutual information are shown in Table 3 at the end of this paper.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
The paper used AMFES-based SVM classification with mutual-information analysis on three GEO datasets—GSE18655, GSE19536, and GSE21036—and selected 96 biomarkers for three-stage prostate cancer, 72 for luminal-versus-basal/normal breast cancer, 68 for basal-like-versus-normal-like breast cancer, and 22 for prostate cancerous-versus-normal classification.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:23031749
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE18655
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE18655
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 7 items
[0] object · 15 fields
id
source:pmid:23031749
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1186/2043-9113-2-16
sha256
sha256:c3d44b6d643ae016c45c67b14579b8593d0343d6caf1d5937d4c2dbf1597f095
bytes
38931
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1186/2043-9113-2-16
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC3524788
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE18655
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18655
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE18655
version
null
note
The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.
access_statement_kind
repository_route_statement
sample_accessions array · 139 items
[0]
GSM463391
[1]
GSM463392
[2]
GSM463393
[3]
GSM463394
[4]
GSM463395
[5]
GSM463396
[6]
GSM463397
[7]
GSM463398
[8]
GSM463399
[9]
GSM463400
[10]
GSM463401
[11]
GSM463403
[12]
GSM463404
[13]
GSM463405
[14]
GSM463406
[15]
GSM463407
[16]
GSM463409
[17]
GSM463411
[18]
GSM463412
[19]
GSM463413
[20]
GSM463414
[21]
GSM463415
[22]
GSM463416
[23]
GSM463417
[24]
GSM463418
[25]
GSM463419
[26]
GSM463420
[27]
GSM463421
[28]
GSM463422
[29]
GSM463423
[30]
GSM463424
[31]
GSM463425
[32]
GSM463427
[33]
GSM463429
[34]
GSM463430
[35]
GSM463431
[36]
GSM463432
[37]
GSM463433
[38]
GSM463434
[39]
GSM463435
[40]
GSM463436
[41]
GSM463437
[42]
GSM463438
[43]
GSM463439
[44]
GSM463440
[45]
GSM463441
[46]
GSM463442
[47]
GSM463443
[48]
GSM463446
[49]
GSM463447
[50]
GSM463448
[51]
GSM463449
[52]
GSM463450
[53]
GSM463451
[54]
GSM463452
[55]
GSM463453
[56]
GSM463454
[57]
GSM463456
[58]
GSM463457
[59]
GSM463458
[60]
GSM463459
[61]
GSM463460
[62]
GSM463461
[63]
GSM463462
[64]
GSM463463
[65]
GSM463464
[66]
GSM463465
[67]
GSM463466
[68]
GSM463467
[69]
GSM463468
[70]
GSM463469
[71]
GSM463470
[72]
GSM463471
[73]
GSM463472
[74]
GSM463473
[75]
GSM463475
[76]
GSM463476
[77]
GSM463477
[78]
GSM463478
[79]
GSM463479
[80]
GSM463480
[81]
GSM463483
[82]
GSM463484
[83]
GSM463485
[84]
GSM463486
[85]
GSM463487
[86]
GSM463489
[87]
GSM463490
[88]
GSM463491
[89]
GSM463492
[90]
GSM463493
[91]
GSM463494
[92]
GSM463495
[93]
GSM463496
[94]
GSM463497
[95]
GSM463498
[96]
GSM463500
[97]
GSM463501
[98]
GSM463502
[99]
GSM463503
[100]
GSM463504
[101]
GSM463505
[102]
GSM463506
[103]
GSM463507
[104]
GSM463508
[105]
GSM463509
[106]
GSM463510
[107]
GSM463511
[108]
GSM463512
[109]
GSM463513
[110]
GSM463514
[111]
GSM463515
[112]
GSM463516
[113]
GSM463517
[114]
GSM463518
[115]
GSM463519
[116]
GSM463522
[117]
GSM463523
[118]
GSM463524
[119]
GSM463525
[120]
GSM463526
[121]
GSM463527
[122]
GSM463528
[123]
GSM463529
[124]
GSM463530
[125]
GSM463531
[126]
GSM463532
[127]
GSM463533
[128]
GSM463536
[129]
GSM463537
[130]
GSM463538
[131]
GSM463540
[132]
GSM463541
[133]
GSM463542
[134]
GSM463544
[135]
GSM463545
[136]
GSM463546
[137]
GSM463547
[138]
GSM463548
sample_count
139
group_sizes
null
group_sizes_basis
null
platform
5858
taxon
Homo sapiens
title
Radical prostatectomy specimens with and without TMPRSS2:ERG fusion from 139 patients with prostate in a Toronto cohort
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:GSE19536
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE19536
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE19536
version
null
note
The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.
access_statement_kind
repository_route_statement
sample_accessions array · 215 items
[0]
GSM487073
[1]
GSM487074
[2]
GSM487075
[3]
GSM487076
[4]
GSM487077
[5]
GSM487078
[6]
GSM487079
[7]
GSM487080
[8]
GSM487081
[9]
GSM487082
[10]
GSM487083
[11]
GSM487084
[12]
GSM487085
[13]
GSM487086
[14]
GSM487087
[15]
GSM487088
[16]
GSM487089
[17]
GSM487090
[18]
GSM487091
[19]
GSM487092
[20]
GSM487093
[21]
GSM487094
[22]
GSM487095
[23]
GSM487096
[24]
GSM487097
[25]
GSM487098
[26]
GSM487099
[27]
GSM487100
[28]
GSM487101
[29]
GSM487102
[30]
GSM487103
[31]
GSM487104
[32]
GSM487105
[33]
GSM487106
[34]
GSM487107
[35]
GSM487108
[36]
GSM487109
[37]
GSM487110
[38]
GSM487111
[39]
GSM487112
[40]
GSM487113
[41]
GSM487114
[42]
GSM487115
[43]
GSM487116
[44]
GSM487117
[45]
GSM487118
[46]
GSM487119
[47]
GSM487120
[48]
GSM487121
[49]
GSM487122
[50]
GSM487123
[51]
GSM487124
[52]
GSM487125
[53]
GSM487126
[54]
GSM487127
[55]
GSM487128
[56]
GSM487129
[57]
GSM487130
[58]
GSM487131
[59]
GSM487132
[60]
GSM487133
[61]
GSM487134
[62]
GSM487135
[63]
GSM487136
[64]
GSM487137
[65]
GSM487138
[66]
GSM487139
[67]
GSM487140
[68]
GSM487141
[69]
GSM487142
[70]
GSM487143
[71]
GSM487144
[72]
GSM487145
[73]
GSM487146
[74]
GSM487147
[75]
GSM487148
[76]
GSM487149
[77]
GSM487150
[78]
GSM487151
[79]
GSM487152
[80]
GSM487153
[81]
GSM487154
[82]
GSM487155
[83]
GSM487156
[84]
GSM487157
[85]
GSM487158
[86]
GSM487159
[87]
GSM487160
[88]
GSM487161
[89]
GSM487162
[90]
GSM487163
[91]
GSM487164
[92]
GSM487165
[93]
GSM487166
[94]
GSM487167
[95]
GSM487168
[96]
GSM487169
[97]
GSM487170
[98]
GSM487171
[99]
GSM487172
[100]
GSM487173
[101]
GSM496924
[102]
GSM496925
[103]
GSM496926
[104]
GSM496927
[105]
GSM496928
[106]
GSM496929
[107]
GSM496930
[108]
GSM496931
[109]
GSM496932
[110]
GSM496933
[111]
GSM496934
[112]
GSM496935
[113]
GSM496936
[114]
GSM496937
[115]
GSM496938
[116]
GSM496939
[117]
GSM496940
[118]
GSM496941
[119]
GSM496942
[120]
GSM496943
[121]
GSM496944
[122]
GSM496945
[123]
GSM496946
[124]
GSM496947
[125]
GSM496948
[126]
GSM496949
[127]
GSM496950
[128]
GSM496951
[129]
GSM496952
[130]
GSM496953
[131]
GSM496954
[132]
GSM496955
[133]
GSM496956
[134]
GSM496957
[135]
GSM496958
[136]
GSM496959
[137]
GSM496960
[138]
GSM496961
[139]
GSM496962
[140]
GSM496963
[141]
GSM496964
[142]
GSM496965
[143]
GSM496966
[144]
GSM496967
[145]
GSM496968
[146]
GSM496969
[147]
GSM496970
[148]
GSM496971
[149]
GSM496972
[150]
GSM496973
[151]
GSM496974
[152]
GSM496975
[153]
GSM496976
[154]
GSM496977
[155]
GSM496978
[156]
GSM496979
[157]
GSM496980
[158]
GSM496981
[159]
GSM496982
[160]
GSM496983
[161]
GSM496984
[162]
GSM496985
[163]
GSM496986
[164]
GSM496987
[165]
GSM496988
[166]
GSM496989
[167]
GSM496990
[168]
GSM496991
[169]
GSM496992
[170]
GSM496993
[171]
GSM496994
[172]
GSM496995
[173]
GSM496996
[174]
GSM496997
[175]
GSM496998
[176]
GSM496999
[177]
GSM497000
[178]
GSM497001
[179]
GSM497002
[180]
GSM497003
[181]
GSM497004
[182]
GSM497005
[183]
GSM497006
[184]
GSM497007
[185]
GSM497008
[186]
GSM497009
[187]
GSM497010
[188]
GSM497011
[189]
GSM497012
[190]
GSM497013
[191]
GSM497014
[192]
GSM497015
[193]
GSM497016
[194]
GSM497017
[195]
GSM497018
[196]
GSM497019
[197]
GSM497020
[198]
GSM497021
[199]
GSM497022
[200]
GSM497023
[201]
GSM497024
[202]
GSM497025
[203]
GSM497026
[204]
GSM497027
[205]
GSM497028
[206]
GSM497029
[207]
GSM497030
[208]
GSM497031
[209]
GSM497032
[210]
GSM497033
[211]
GSM497034
[212]
GSM497035
[213]
GSM497036
[214]
GSM497037
sample_count
215
group_sizes
null
group_sizes_basis
null
platform
6480;8227
taxon
Homo sapiens
title
Molecular Characterization of Breast Cancer Subtypes Derived from Joint Analysis of High Throughput miRNA and mRNA Data
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[3] object · 15 fields
id
data:geo:GSE21036
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21036
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE21036
version
null
note
The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.
access_statement_kind
repository_route_statement
sample_accessions array · 142 items
[0]
GSM526419
[1]
GSM526420
[2]
GSM526421
[3]
GSM526422
[4]
GSM526423
[5]
GSM526424
[6]
GSM526425
[7]
GSM526426
[8]
GSM526427
[9]
GSM526428
[10]
GSM526429
[11]
GSM526430
[12]
GSM526431
[13]
GSM526432
[14]
GSM526433
[15]
GSM526434
[16]
GSM526435
[17]
GSM526436
[18]
GSM526437
[19]
GSM526438
[20]
GSM526439
[21]
GSM526440
[22]
GSM526441
[23]
GSM526442
[24]
GSM526443
[25]
GSM526444
[26]
GSM526445
[27]
GSM526446
[28]
GSM526447
[29]
GSM526448
[30]
GSM526449
[31]
GSM526450
[32]
GSM526451
[33]
GSM526452
[34]
GSM526453
[35]
GSM526454
[36]
GSM526455
[37]
GSM526456
[38]
GSM526457
[39]
GSM526458
[40]
GSM526459
[41]
GSM526460
[42]
GSM526461
[43]
GSM526462
[44]
GSM526463
[45]
GSM526464
[46]
GSM526465
[47]
GSM526466
[48]
GSM526467
[49]
GSM526468
[50]
GSM526469
[51]
GSM526470
[52]
GSM526471
[53]
GSM526472
[54]
GSM526473
[55]
GSM526474
[56]
GSM526475
[57]
GSM526476
[58]
GSM526477
[59]
GSM526478
[60]
GSM526479
[61]
GSM526480
[62]
GSM526481
[63]
GSM526482
[64]
GSM526483
[65]
GSM526484
[66]
GSM526485
[67]
GSM526486
[68]
GSM526487
[69]
GSM526488
[70]
GSM526489
[71]
GSM526490
[72]
GSM526491
[73]
GSM526492
[74]
GSM526493
[75]
GSM526494
[76]
GSM526495
[77]
GSM526496
[78]
GSM526497
[79]
GSM526498
[80]
GSM526499
[81]
GSM526500
[82]
GSM526501
[83]
GSM526502
[84]
GSM526503
[85]
GSM526504
[86]
GSM526505
[87]
GSM526506
[88]
GSM526507
[89]
GSM526508
[90]
GSM526509
[91]
GSM526510
[92]
GSM526511
[93]
GSM526512
[94]
GSM526513
[95]
GSM526514
[96]
GSM526515
[97]
GSM526516
[98]
GSM526517
[99]
GSM526518
[100]
GSM526519
[101]
GSM526520
[102]
GSM526521
[103]
GSM526522
[104]
GSM526523
[105]
GSM526524
[106]
GSM526525
[107]
GSM526526
[108]
GSM526527
[109]
GSM526528
[110]
GSM526529
[111]
GSM526530
[112]
GSM526531
[113]
GSM526532
[114]
GSM526533
[115]
GSM526534
[116]
GSM526535
[117]
GSM526536
[118]
GSM526537
[119]
GSM526538
[120]
GSM526539
[121]
GSM526540
[122]
GSM526541
[123]
GSM526542
[124]
GSM526543
[125]
GSM526544
[126]
GSM526545
[127]
GSM526546
[128]
GSM526547
[129]
GSM526548
[130]
GSM526549
[131]
GSM526550
[132]
GSM526551
[133]
GSM526552
[134]
GSM526553
[135]
GSM526554
[136]
GSM526555
[137]
GSM526556
[138]
GSM526557
[139]
GSM526558
[140]
GSM526559
[141]
GSM526560
sample_count
142
group_sizes
null
group_sizes_basis
null
platform
8227
taxon
Homo sapiens
title
MicroRNA expression data for human primary and metastatic prostate cancer samples and control normal adjacent benign prostate
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[4] object · 16 fields
id
asset:table:pmid:23031749:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:712f031f7397b7021a29906ecf5162db3039b26bc51a0957a77d17118ae24c0e
bytes
636
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[13]/table-wrap[1]#T1
version
null
note
Descriptions of 3 datasets:GSE18655 (prostate cancer), GSE19536(breast cancer) and GSE21036(prostate cancer)
structure object · 5 fields
pmcid
PMC3524788
section_index
13
section_title
MIROARRAY data description
row_count
5
column_count
4
table object · 8 fields
label
Table 1
caption
Descriptions of 3 datasets:GSE18655 (prostate cancer), GSE19536(breast cancer) and GSE21036(prostate cancer)
rows array · 5 items
[0] array · 4 items
[0]
[1]
Prostate Cancer (GSE18655)
[2]
Breast Cancer (GSE19536)
[3]
Prostate Cancer (GSE21036)
[1] array · 4 items
[0]
Number of Biomarkers
[1]
502
[2]
489
[3]
373
[2] array · 4 items
[0]
Type of Biomarkers
[1]
RNAs
[2]
miRNAs
[3]
miRNAs
[3] array · 4 items
[0]
Number of Samples
[1]
139
[2]
78
[3]
142
[4] array · 4 items
[0]
Variation of Samples
[1]
Grade1(38), Grade2(90), Grade3(11)
[2]
Luminal A ( 41), Luminal B (12), Basal-like (15), Normal-like(10)
[3]
Cancerous (114), Normal(28)
locator
section[13]/table-wrap[1]#T1
[5] object · 16 fields
id
asset:table:pmid:23031749:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:60d49ce1a16aeab80fbd9b2d511761c67e8828a8349aa466c9ac6e6362d2e125
bytes
470
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[1]#T2
version
null
note
Results of selected subsetsof genes
structure object · 5 fields
pmcid
PMC3524788
section_index
17
section_title
Results of AMFES
row_count
3
column_count
5
table object · 8 fields
label
Table 2
caption
Results of selected subsetsof genes
rows array · 3 items
[0] array · 5 items
[0]
[1]
Prostate Cancer (GSE18655)
[2]
Breast Cancer (GSE19536)
[3]
Breast Cancer (GSE19536)
[4]
Prostate Cancer (GSE21036)
[1] array · 5 items
[0]
Number of Biomarkers Selected
[1]
96
[2]
72
[3]
68
[4]
22
[2] array · 5 items
[0]
Variation of Samples
[1]
Grade1, Grade2, Grade3
[2]
Luminal A, Luminal B
[3]
Basal-like Normal-like
[4]
Cancerous Normal
locator
section[17]/table-wrap[1]#T2
[6] object · 16 fields
id
asset:table:pmid:23031749:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:4e0f87c7c529ee475a3d9f6a1dc6ad57a05855d145d30d19b06a8237e607887a
bytes
1041
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[2]#T3
version
null
note
Results of analysis ofMI matrices
structure object · 5 fields
pmcid
PMC3524788
section_index
17
section_title
Results of AMFES
row_count
10
column_count
8
table object · 8 fields
label
Table 3
caption
Results of analysis ofMI matrices
rows array · 10 items
[0] array · 8 items
[0]
[1]
Mean value of MI
[2]
Standard deviation of MI
[3]
Num of positive values
[4]
Num of negative values
[5]
Num of values ofdifferent sign
[6]
Min value
[7]
Max value
[1] array · 8 items
[0]
GSE18655_grade1
[1]
0.00024
[2]
0.0015
[3]
6298
[4]
2918
[5]
N/A
[6]
−0.0011
[7]
0.0858
[2] array · 8 items
[0]
GSE18655_grade2
[1]
0.00020
[2]
0.0017
[3]
6468
[4]
2748
[5]
[6]
−0.0018
[7]
0.0949
[3] array · 8 items
[0]
GSE18655_grade3
[1]
0.0004
[2]
0.0021
[3]
6650
[4]
2566
[5]
[6]
−0.0029
[7]
0.0582
[4] array · 8 items
[0]
GSE19536_A(72)
[1]
0.00036
[2]
0.0022
[3]
3912
[4]
1272
[5]
2052
[6]
−0.0010
[7]
0.1293
[5] array · 8 items
[0]
GSE19536_B(72)
[1]
0.00053
[2]
0.0040
[3]
3388
[4]
1796
[5]
[6]
−0.0022
[7]
0.2279
[6] array · 8 items
[0]
GSE19536_BasalLike(68)
[1]
0.0017
[2]
0.0056
[3]
3491
[4]
998
[5]
1217
[6]
−0.0033
[7]
0.1648
[7] array · 8 items
[0]
GSE19536_NormalLike(68)
[1]
0.0056
[2]
0.008
[3]
4200
[4]
420
[5]
[6]
−0.002
[7]
0.1279
[8] array · 8 items
[0]
GSE21036_cancer
[1]
0.0165
[2]
0.0212
[3]
10
[4]
474
[5]
56
[6]
−0.002
[7]
0.1446
[9] array · 8 items
[0]
GSE21036_norm
[1]
0.0086
[2]
0.0146
[3]
46
[4]
438
[5]
[6]
−0.0015
[7]
0.1565
locator
section[17]/table-wrap[2]#T3
gaps array · 6 items
[0]
asset:data:geo:GSE18655 not downloaded
[1]
asset:data:geo:GSE18655 licence not read
[2]
asset:data:geo:GSE19536 not downloaded
[3]
asset:data:geo:GSE19536 licence not read
[4]
asset:data:geo:GSE21036 not downloaded
[5]
asset:data:geo:GSE21036 licence not read
analysis object · 4 fields
state
partial
methods array · 2 items
[0] object · 10 fields
id
method-1
family
machine_learning
specific
support_vector_machine
label
Machine learning
dsl_operations array · 3 items
[0]
train_classifier
[1]
cross_validate
[2]
roc_auc
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
labelled_feature_matrix
evidence object · 3 fields
score
0.7
band
medium
quote
SVM
[1] object · 10 fields
id
method-2
family
null
specific
null
label
Mutual information (MI)
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
We then apply the MI calculation described in the Mutual Information section on 96 biomarkers for GSE18655 and represent the pairwise MI values of grade 1, grade 2 and grade 3 samples in three 96*96 matrixes which can be found in Additional file 5 GSE18655 Grade1 MI.xlsx, Additional file 6 GSE18655 Grade2 MI.xlsx and Additional file 7 GSE18655 Grade3 MI.xlsx.
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 3 items
[0]
train_classifier
[1]
cross_validate
[2]
roc_auc
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: support_vector_machine.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 3 items
[0]
GSE18655
[1]
GSE19536
[2]
GSE21036
resolved_accessions array · 3 items
[0]
GSE18655
[1]
GSE19536
[2]
GSE21036
statements array · 1 item
[0]
The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.
basis
The paper names GSE18655, GSE19536, GSE21036 in GEO and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 3 items
[0]
train_classifier
[1]
cross_validate
[2]
roc_auc
assets array · 5 items
[0]
source:pmid:23031749
[1]
data:geo:GSE18655
[2]
asset:table:pmid:23031749:1
[3]
asset:table:pmid:23031749:2
[4]
asset:table:pmid:23031749:3
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE18655
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:21:09Z
independence
same_provider
evidence_check object · 2 fields
method
verbatim
availability
null
calls
8
usage object · 3 fields
prompt_tokens
81102
completion_tokens
3967
cached_tokens
61412
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:23031749
type
paper
label
pmid:23031749
[1] object · 3 fields
id
source:pmid:23031749
type
manuscript
label
PMID 23031749 full text
[2] object · 3 fields
id
data:geo:GSE18655
type
dataset
label
GEO GSE18655
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:23031749
type
paper
label
pmid:23031749
[1] object · 3 fields
id
source:pmid:23031749
type
manuscript
label
PMID 23031749 full text
[2] object · 3 fields
id
data:geo:GSE18655
type
dataset
label
GEO GSE18655
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-23031749
type
extraction
used array · 1 item
[0]
source:pmid:23031749
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE18655
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE18655
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:23031749
parent_hash
sha256:0bf9ec907dfe083b2de3949fbf5f3e8785c9e01e0e250fc5dc94b5875c84216d
fork_of
null
gaps array · 11 items
[0]
asset:data:geo:GSE18655 licence not read
[1]
asset:data:geo:GSE18655 not downloaded
[2]
asset:data:geo:GSE19536 licence not read
[3]
asset:data:geo:GSE19536 not downloaded
[4]
asset:data:geo:GSE21036 licence not read
[5]
asset:data:geo:GSE21036 not downloaded
[6]
execution.not_run
[7]
method.reader_named_unmapped
[8]
review.human_critique
[9]
review.independent_reader
[10]
review.machine_critique
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_id
microarray
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
we only use the GSE 21036 for analysis. The microarray dataset has 142 samples which include 114 pr
[1]
. The platform is Agilent-019118 Human miRNA Microarray 2.0 G4470B (miRNA ID version). Supplementary
order_basis
paper_text_order:2791
id
assay:1
[1] object · 11 fields
role
analysis
definition_id
machine_learning
definition_version
f2132e96ae6c7a4e
required_operations array · 3 items
[0]
train_classifier
[1]
cross_validate
[2]
roc_auc
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
SVM
order_basis
consumes_earlier_output
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:23031749", "kind": "science-record", "revision": 8, "content_hash": "sha256:67b0d56230521bcc070349e1daa0fcd1d2aa745b0f7fa5d635276a22cdb08850", "created_at": "2026-11-01T15:40:02Z", "updated_at": "2026-11-01T21:58:09Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Cancer classification: Mutual information, target network and strategies of therapy.", "doi": "10.1186/2043-9113-2-16", "pmid": "23031749", "authors": ["Wen-Chin Hsu", "Chan-Cheng Liu", "Fu Chang", "Su-Shing Chen"], "journal": "Journal of clinical bioinformatics", "year": 2012, "abstract": "BACKGROUND: Cancer therapy is a challenging research area because side effects often occur in chemo and radiation therapy. We intend to study a multi-targets and multi-components design that will provide synergistic results to improve efficiency of cancer therapy.\nMETHODS: We have developed a general methodology, AMFES (Adaptive Multiple FEature Selection), for ranking and selecting important cancer biomarkers based on SVM (Support Vector Machine) classification. In particular, we exemplify this method by three datasets: a prostate cancer (three stages), a breast cancer (four subtypes), and another prostate cancer (normal vs. cancerous). Moreover, we have computed the target networks of these biomarkers as the signatures of the cancers with additional information (mutual information between biomarkers of the network). Then, we proposed a robust framework for synergistic therapy design approach which includes varies existing mechanisms.\nRESULTS: These methodologies were applied to three GEO datasets: GSE18655 (three prostate stages), GSE19536 (4 subtypes breast cancers) and GSE21036 (prostate cancer cells and normal cells) shown in. We selected 96 biomarkers for first prostate cancer dataset (three prostate stages), 72 for breast cancer (luminal A vs. luminal B), 68 for breast cancer (basal-like vs. normal-like), and 22 for another prostate cancer (cancerous vs. normal. In addition, we obtained statistically significant results of mutual information, which demonstrate that the dependencies among these biomarkers can be positive or negative.\nCONCLUSIONS: We proposed an efficient feature ranking and selection scheme, AMFES, to select an important subset from a large number of features for any cancer dataset. Thus, we obtained the signatures of these cancers by building their target networks. Finally, we proposed a robust framework of synergistic therapy for cancer patients. Our framework is not only supported by real GEO datasets but also aim to a multi-targets/multi-components drug design tool, which improves the traditional single target/single component analysis methods. This framework builds a computational foundation which can provide a clear classification of cancers and lead to an efficient cancer therapy.", "claims": [{"id": "claim-method", "statement": "We then apply the MI calculation described in the Mutual Information section on 96 biomarkers for GSE18655 and represent the pairwise MI values of grade 1, grade 2 and grade 3 samples in three 96*96 matrixes which can be found in Additional file 5 GSE18655 Grade1 MI.xlsx, Additional file 6 GSE18655 Grade2 MI.xlsx and Additional file 7 GSE18655 Grade3 MI.xlsx.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:23031749", "locator": "sections[17] \"Results of AMFES\" paragraph 4", "quote": "We then apply the MI calculation described in the Mutual Information section on 96 biomarkers for GSE18655 and represent the pairwise MI values of grade 1, grade 2 and grade 3 samples in three 96*96 matrixes which can be found in Additional file 5 GSE18655 Grade1 MI.xlsx, Additional file 6 GSE18655 Grade2 MI.xlsx and Additional file 7 GSE18655 Grade3 MI.xlsx."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:23031749", "locator": "sections[14] \"The prostate cancer dataset with RNA biomarkers\" paragraph 3", "quote": "The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]."}, {"asset": "source:pmid:23031749", "locator": "sections[14] \"The prostate cancer dataset with RNA biomarkers\" paragraph 3", "quote": "Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3."}], "state": "complete"}, {"id": "claim-target-result", "statement": "The paper used AMFES-based SVM classification with mutual-information analysis on three GEO datasets—GSE18655, GSE19536, and GSE21036—and selected 96 biomarkers for three-stage prostate cancer, 72 for luminal-versus-basal/normal breast cancer, 68 for basal-like-versus-normal-like breast cancer, and 22 for prostate cancerous-versus-normal classification.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:23031749", "locator": "sections[0] \"Abstract\" paragraph 2", "quote": "We have developed a general methodology, AMFES (Adaptive Multiple FEature Selection), for ranking and selecting important cancer biomarkers based on SVM (Support Vector Machine) classification."}, {"asset": "source:pmid:23031749", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "These methodologies were applied to three GEO datasets: GSE18655 (three prostate stages), GSE19536 (4 subtypes breast cancers) and GSE21036 (prostate cancer cells and normal cells) shown in."}, {"asset": "source:pmid:23031749", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "We selected 96 biomarkers for first prostate cancer dataset (three prostate stages), 72 for breast cancer (luminal A vs. luminal B), 68 for breast cancer (basal-like vs. normal-like), and 22 for another prostate cancer (cancerous vs. normal."}, {"asset": "source:pmid:23031749", "locator": "sections[18] \"Results of calculating mutual information\" paragraph 2", "quote": "The statistic results of calculating mutual information are shown in Table 3 at the end of this paper."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "The paper used AMFES-based SVM classification with mutual-information analysis on three GEO datasets—GSE18655, GSE19536, and GSE21036—and selected 96 biomarkers for three-stage prostate cancer, 72 for luminal-versus-basal/normal breast cancer, 68 for basal-like-versus-normal-like breast cancer, and 22 for prostate cancerous-versus-normal classification.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:23031749"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE18655"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE18655"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:23031749", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1186/2043-9113-2-16", "sha256": "sha256:c3d44b6d643ae016c45c67b14579b8593d0343d6caf1d5937d4c2dbf1597f095", "bytes": 38931, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1186/2043-9113-2-16", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC3524788", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE18655", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18655", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE18655", "version": null, "note": "The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM463391", "GSM463392", "GSM463393", "GSM463394", "GSM463395", "GSM463396", "GSM463397", "GSM463398", "GSM463399", "GSM463400", "GSM463401", "GSM463403", "GSM463404", "GSM463405", "GSM463406", "GSM463407", "GSM463409", "GSM463411", "GSM463412", "GSM463413", "GSM463414", "GSM463415", "GSM463416", "GSM463417", "GSM463418", "GSM463419", "GSM463420", "GSM463421", "GSM463422", "GSM463423", "GSM463424", "GSM463425", "GSM463427", "GSM463429", "GSM463430", "GSM463431", "GSM463432", "GSM463433", "GSM463434", "GSM463435", "GSM463436", "GSM463437", "GSM463438", "GSM463439", "GSM463440", "GSM463441", "GSM463442", "GSM463443", "GSM463446", "GSM463447", "GSM463448", "GSM463449", "GSM463450", "GSM463451", "GSM463452", "GSM463453", "GSM463454", "GSM463456", "GSM463457", "GSM463458", "GSM463459", "GSM463460", "GSM463461", "GSM463462", "GSM463463", "GSM463464", "GSM463465", "GSM463466", "GSM463467", "GSM463468", "GSM463469", "GSM463470", "GSM463471", "GSM463472", "GSM463473", "GSM463475", "GSM463476", "GSM463477", "GSM463478", "GSM463479", "GSM463480", "GSM463483", "GSM463484", "GSM463485", "GSM463486", "GSM463487", "GSM463489", "GSM463490", "GSM463491", "GSM463492", "GSM463493", "GSM463494", "GSM463495", "GSM463496", "GSM463497", "GSM463498", "GSM463500", "GSM463501", "GSM463502", "GSM463503", "GSM463504", "GSM463505", "GSM463506", "GSM463507", "GSM463508", "GSM463509", "GSM463510", "GSM463511", "GSM463512", "GSM463513", "GSM463514", "GSM463515", "GSM463516", "GSM463517", "GSM463518", "GSM463519", "GSM463522", "GSM463523", "GSM463524", "GSM463525", "GSM463526", "GSM463527", "GSM463528", "GSM463529", "GSM463530", "GSM463531", "GSM463532", "GSM463533", "GSM463536", "GSM463537", "GSM463538", "GSM463540", "GSM463541", "GSM463542", "GSM463544", "GSM463545", "GSM463546", "GSM463547", "GSM463548"], "sample_count": 139, "group_sizes": null, "group_sizes_basis": null, "platform": "5858", "taxon": "Homo sapiens", "title": "Radical prostatectomy specimens with and without TMPRSS2:ERG fusion from 139 patients with prostate in a Toronto cohort", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE19536", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE19536", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE19536", "version": null, "note": "The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM487073", "GSM487074", "GSM487075", "GSM487076", "GSM487077", "GSM487078", "GSM487079", "GSM487080", "GSM487081", "GSM487082", "GSM487083", "GSM487084", "GSM487085", "GSM487086", "GSM487087", "GSM487088", "GSM487089", "GSM487090", "GSM487091", "GSM487092", "GSM487093", "GSM487094", "GSM487095", "GSM487096", "GSM487097", "GSM487098", "GSM487099", "GSM487100", "GSM487101", "GSM487102", "GSM487103", "GSM487104", "GSM487105", "GSM487106", "GSM487107", "GSM487108", "GSM487109", "GSM487110", "GSM487111", "GSM487112", "GSM487113", "GSM487114", "GSM487115", "GSM487116", "GSM487117", "GSM487118", "GSM487119", "GSM487120", "GSM487121", "GSM487122", "GSM487123", "GSM487124", "GSM487125", "GSM487126", "GSM487127", "GSM487128", "GSM487129", "GSM487130", "GSM487131", "GSM487132", "GSM487133", "GSM487134", "GSM487135", "GSM487136", "GSM487137", "GSM487138", "GSM487139", "GSM487140", "GSM487141", "GSM487142", "GSM487143", "GSM487144", "GSM487145", "GSM487146", "GSM487147", "GSM487148", "GSM487149", "GSM487150", "GSM487151", "GSM487152", "GSM487153", "GSM487154", "GSM487155", "GSM487156", "GSM487157", "GSM487158", "GSM487159", "GSM487160", "GSM487161", "GSM487162", "GSM487163", "GSM487164", "GSM487165", "GSM487166", "GSM487167", "GSM487168", "GSM487169", "GSM487170", "GSM487171", "GSM487172", "GSM487173", "GSM496924", "GSM496925", "GSM496926", "GSM496927", "GSM496928", "GSM496929", "GSM496930", "GSM496931", "GSM496932", "GSM496933", "GSM496934", "GSM496935", "GSM496936", "GSM496937", "GSM496938", "GSM496939", "GSM496940", "GSM496941", "GSM496942", "GSM496943", "GSM496944", "GSM496945", "GSM496946", "GSM496947", "GSM496948", "GSM496949", "GSM496950", "GSM496951", "GSM496952", "GSM496953", "GSM496954", "GSM496955", "GSM496956", "GSM496957", "GSM496958", "GSM496959", "GSM496960", "GSM496961", "GSM496962", "GSM496963", "GSM496964", "GSM496965", "GSM496966", "GSM496967", "GSM496968", "GSM496969", "GSM496970", "GSM496971", "GSM496972", "GSM496973", "GSM496974", "GSM496975", "GSM496976", "GSM496977", "GSM496978", "GSM496979", "GSM496980", "GSM496981", "GSM496982", "GSM496983", "GSM496984", "GSM496985", "GSM496986", "GSM496987", "GSM496988", "GSM496989", "GSM496990", "GSM496991", "GSM496992", "GSM496993", "GSM496994", "GSM496995", "GSM496996", "GSM496997", "GSM496998", "GSM496999", "GSM497000", "GSM497001", "GSM497002", "GSM497003", "GSM497004", "GSM497005", "GSM497006", "GSM497007", "GSM497008", "GSM497009", "GSM497010", "GSM497011", "GSM497012", "GSM497013", "GSM497014", "GSM497015", "GSM497016", "GSM497017", "GSM497018", "GSM497019", "GSM497020", "GSM497021", "GSM497022", "GSM497023", "GSM497024", "GSM497025", "GSM497026", "GSM497027", "GSM497028", "GSM497029", "GSM497030", "GSM497031", "GSM497032", "GSM497033", "GSM497034", "GSM497035", "GSM497036", "GSM497037"], "sample_count": 215, "group_sizes": null, "group_sizes_basis": null, "platform": "6480;8227", "taxon": "Homo sapiens", "title": "Molecular Characterization of Breast Cancer Subtypes Derived from Joint Analysis of High Throughput miRNA and mRNA Data", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE21036", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21036", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE21036", "version": null, "note": "The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3.", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM526419", "GSM526420", "GSM526421", "GSM526422", "GSM526423", "GSM526424", "GSM526425", "GSM526426", "GSM526427", "GSM526428", "GSM526429", "GSM526430", "GSM526431", "GSM526432", "GSM526433", "GSM526434", "GSM526435", "GSM526436", "GSM526437", "GSM526438", "GSM526439", "GSM526440", "GSM526441", "GSM526442", "GSM526443", "GSM526444", "GSM526445", "GSM526446", "GSM526447", "GSM526448", "GSM526449", "GSM526450", "GSM526451", "GSM526452", "GSM526453", "GSM526454", "GSM526455", "GSM526456", "GSM526457", "GSM526458", "GSM526459", "GSM526460", "GSM526461", "GSM526462", "GSM526463", "GSM526464", "GSM526465", "GSM526466", "GSM526467", "GSM526468", "GSM526469", "GSM526470", "GSM526471", "GSM526472", "GSM526473", "GSM526474", "GSM526475", "GSM526476", "GSM526477", "GSM526478", "GSM526479", "GSM526480", "GSM526481", "GSM526482", "GSM526483", "GSM526484", "GSM526485", "GSM526486", "GSM526487", "GSM526488", "GSM526489", "GSM526490", "GSM526491", "GSM526492", "GSM526493", "GSM526494", "GSM526495", "GSM526496", "GSM526497", "GSM526498", "GSM526499", "GSM526500", "GSM526501", "GSM526502", "GSM526503", "GSM526504", "GSM526505", "GSM526506", "GSM526507", "GSM526508", "GSM526509", "GSM526510", "GSM526511", "GSM526512", "GSM526513", "GSM526514", "GSM526515", "GSM526516", "GSM526517", "GSM526518", "GSM526519", "GSM526520", "GSM526521", "GSM526522", "GSM526523", "GSM526524", "GSM526525", "GSM526526", "GSM526527", "GSM526528", "GSM526529", "GSM526530", "GSM526531", "GSM526532", "GSM526533", "GSM526534", "GSM526535", "GSM526536", "GSM526537", "GSM526538", "GSM526539", "GSM526540", "GSM526541", "GSM526542", "GSM526543", "GSM526544", "GSM526545", "GSM526546", "GSM526547", "GSM526548", "GSM526549", "GSM526550", "GSM526551", "GSM526552", "GSM526553", "GSM526554", "GSM526555", "GSM526556", "GSM526557", "GSM526558", "GSM526559", "GSM526560"], "sample_count": 142, "group_sizes": null, "group_sizes_basis": null, "platform": "8227", "taxon": "Homo sapiens", "title": "MicroRNA expression data for human primary and metastatic prostate cancer samples and control normal adjacent benign prostate", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:23031749:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:712f031f7397b7021a29906ecf5162db3039b26bc51a0957a77d17118ae24c0e", "bytes": 636, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[13]/table-wrap[1]#T1", "version": null, "note": "Descriptions of 3 datasets:GSE18655 (prostate cancer), GSE19536(breast cancer) and GSE21036(prostate cancer)", "structure": {"pmcid": "PMC3524788", "section_index": 13, "section_title": "MIROARRAY data description", "row_count": 5, "column_count": 4}, "table": {"label": "Table 1", "caption": "Descriptions of 3 datasets:GSE18655 (prostate cancer), GSE19536(breast cancer) and GSE21036(prostate cancer)", "rows": [["", "Prostate Cancer (GSE18655)", "Breast Cancer (GSE19536)", "Prostate Cancer (GSE21036)"], ["Number of Biomarkers", "502", "489", "373"], ["Type of Biomarkers", "RNAs", "miRNAs", "miRNAs"], ["Number of Samples", "139", "78", "142"], ["Variation of Samples", "Grade1(38), Grade2(90), Grade3(11)", "Luminal A ( 41), Luminal B (12), Basal-like (15), Normal-like(10)", "Cancerous (114), Normal(28)"]], "row_count": 5, "column_count": 4, "numeric_cells": 12, "header_rows": 1, "locator": "section[13]/table-wrap[1]#T1"}}, {"id": "asset:table:pmid:23031749:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:60d49ce1a16aeab80fbd9b2d511761c67e8828a8349aa466c9ac6e6362d2e125", "bytes": 470, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[1]#T2", "version": null, "note": "Results of selected subsetsof genes", "structure": {"pmcid": "PMC3524788", "section_index": 17, "section_title": "Results of AMFES", "row_count": 3, "column_count": 5}, "table": {"label": "Table 2", "caption": "Results of selected subsetsof genes", "rows": [["", "Prostate Cancer (GSE18655)", "Breast Cancer (GSE19536)", "Breast Cancer (GSE19536)", "Prostate Cancer (GSE21036)"], ["Number of Biomarkers Selected", "96", "72", "68", "22"], ["Variation of Samples", "Grade1, Grade2, Grade3", "Luminal A, Luminal B", "Basal-like Normal-like", "Cancerous Normal"]], "row_count": 3, "column_count": 5, "numeric_cells": 8, "header_rows": 1, "locator": "section[17]/table-wrap[1]#T2"}}, {"id": "asset:table:pmid:23031749:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:4e0f87c7c529ee475a3d9f6a1dc6ad57a05855d145d30d19b06a8237e607887a", "bytes": 1041, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[2]#T3", "version": null, "note": "Results of analysis ofMI matrices", "structure": {"pmcid": "PMC3524788", "section_index": 17, "section_title": "Results of AMFES", "row_count": 10, "column_count": 8}, "table": {"label": "Table 3", "caption": "Results of analysis ofMI matrices", "rows": [["", "Mean value of MI", "Standard deviation of MI", "Num of positive values", "Num of negative values", "Num of values ofdifferent sign", "Min value", "Max value"], ["GSE18655_grade1", "0.00024", "0.0015", "6298", "2918", "N/A", "−0.0011", "0.0858"], ["GSE18655_grade2", "0.00020", "0.0017", "6468", "2748", "", "−0.0018", "0.0949"], ["GSE18655_grade3", "0.0004", "0.0021", "6650", "2566", "", "−0.0029", "0.0582"], ["GSE19536_A(72)", "0.00036", "0.0022", "3912", "1272", "2052", "−0.0010", "0.1293"], ["GSE19536_B(72)", "0.00053", "0.0040", "3388", "1796", "", "−0.0022", "0.2279"], ["GSE19536_BasalLike(68)", "0.0017", "0.0056", "3491", "998", "1217", "−0.0033", "0.1648"], ["GSE19536_NormalLike(68)", "0.0056", "0.008", "4200", "420", "", "−0.002", "0.1279"], ["GSE21036_cancer", "0.0165", "0.0212", "10", "474", "56", "−0.002", "0.1446"], ["GSE21036_norm", "0.0086", "0.0146", "46", "438", "", "−0.0015", "0.1565"]], "row_count": 10, "column_count": 8, "numeric_cells": 66, "header_rows": 1, "locator": "section[17]/table-wrap[2]#T3"}}], "gaps": ["asset:data:geo:GSE18655 not downloaded", "asset:data:geo:GSE18655 licence not read", "asset:data:geo:GSE19536 not downloaded", "asset:data:geo:GSE19536 licence not read", "asset:data:geo:GSE21036 not downloaded", "asset:data:geo:GSE21036 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "machine_learning", "specific": "support_vector_machine", "label": "Machine learning", "dsl_operations": ["train_classifier", "cross_validate", "roc_auc"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["labelled_feature_matrix"], "evidence": {"score": 0.7, "band": "medium", "quote": "SVM"}}, {"id": "method-2", "family": null, "specific": null, "label": "Mutual information (MI)", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "We then apply the MI calculation described in the Mutual Information section on 96 biomarkers for GSE18655 and represent the pairwise MI values of grade 1, grade 2 and grade 3 samples in three 96*96 matrixes which can be found in Additional file 5 GSE18655 Grade1 MI.xlsx, Additional file 6 GSE18655 Grade2 MI.xlsx and Additional file 7 GSE18655 Grade3 MI.xlsx."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["train_classifier", "cross_validate", "roc_auc"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: support_vector_machine."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE18655", "GSE19536", "GSE21036"], "resolved_accessions": ["GSE18655", "GSE19536", "GSE21036"], "statements": ["The prostate cancer dataset, GSE18655, includes 139 patients with 502 molecular markers, RNAs [21]. Among these patients, 38 patient samples have GS 5–6 corresponding to histologic grade 1, 90 samples have GS 7 corresponding to histologic grade 2 and 11 samples have GS 8–9 corresponding to histologic grade 3."], "basis": "The paper names GSE18655, GSE19536, GSE21036 in GEO and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["train_classifier", "cross_validate", "roc_auc"], "assets": ["source:pmid:23031749", "data:geo:GSE18655", "asset:table:pmid:23031749:1", "asset:table:pmid:23031749:2", "asset:table:pmid:23031749:3"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE18655"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:21:09Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": null}, "calls": 8, "usage": {"prompt_tokens": 81102, "completion_tokens": 3967, "cached_tokens": 61412}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:23031749", "type": "paper", "label": "pmid:23031749"}, {"id": "source:pmid:23031749", "type": "manuscript", "label": "PMID 23031749 full text"}, {"id": "data:geo:GSE18655", "type": "dataset", "label": "GEO GSE18655"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:23031749", "type": "paper", "label": "pmid:23031749"}, {"id": "source:pmid:23031749", "type": "manuscript", "label": "PMID 23031749 full text"}, {"id": "data:geo:GSE18655", "type": "dataset", "label": "GEO GSE18655"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-23031749", "type": "extraction", "used": ["source:pmid:23031749"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE18655", "type": "accession_resolution", "used": ["data:geo:GSE18655"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:23031749", "parent_hash": "sha256:0bf9ec907dfe083b2de3949fbf5f3e8785c9e01e0e250fc5dc94b5875c84216d", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:GSE18655 licence not read", "asset:data:geo:GSE18655 not downloaded", "asset:data:geo:GSE19536 licence not read", "asset:data:geo:GSE19536 not downloaded", "asset:data:geo:GSE21036 licence not read", "asset:data:geo:GSE21036 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["we only use the GSE 21036 for analysis. The microarray dataset has 142 samples which include 114 pr", ". The platform is Agilent-019118 Human miRNA Microarray 2.0 G4470B (miRNA ID version). Supplementary"], "order_basis": "paper_text_order:2791", "id": "assay:1"}, {"role": "analysis", "definition_id": "machine_learning", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["train_classifier", "cross_validate", "roc_auc"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.7, "evidence": ["SVM"], "order_basis": "consumes_earlier_output", "id": "assay:2"}]}